Top Companies in Pet Biotics Market

The pet biotics market is projected to grow at a robust compound annual growth rate (CAGR) of 7.0%, from USD 878.1 million in 2025 to USD 1,232.5 million by 2030, driven by rising pet ownership, the premiumization of pet nutrition products, and growing awareness among pet parents about digestive and immune health in animals. Increasing preference for natural and functional ingredients in pet food, alongside concerns over antibiotic resistance and chemical additives, is significantly boosting the adoption of pet biotics. Products powered by probiotics, prebiotics, and postbiotics are gaining widespread acceptance as reliable solutions for maintaining gut microbiome balance, improving nutrient absorption, and enhancing overall wellness in companion animals. Emerging applications in skin and coat health, stress and anxiety management, metabolic balance, and geriatric animal care are creating new opportunities within the market.

Collaborations between global pet food manufacturers, veterinary research institutions, biotechnology firms, and microbiome scientists are accelerating innovation and commercialization of advanced pet biotic formulations across dry and wet pet food, treats, supplements, and veterinary therapeutic diets. Companies are focusing on targeted strain development, heat- and pressure-stable formulations, and species-specific solutions for dogs, cats, and equine animals. As pet biotics increasingly demonstrate strong clinical efficacy and longer shelf stability compared to live probiotics, they are becoming a versatile alternative that aligns with modern processing methods, such as extrusion and high-temperature manufacturing. With strong demand for science-backed nutrition and personalized pet care, the pet biotics market is expected to witness rapid expansion in the coming years.

To know about the assumptions considered for the study download the pdf brochure

Market growth in the pet biotics market is driven by several factors, including rising pet ownership, growing consumer awareness of gut and immune health in companion animals, and increasing prevalence of digestive disorders, allergies, and obesity in pets. The trend of pet humanization is significantly increasing the demand for premium, natural, and science-backed nutrition solutions, which is driving the adoption of biotics, including probiotics, prebiotics, and postbiotics, in pet food and supplements. The increasing understanding of the gut–brain–skin axis in pets and its impact on behavior, immunity, and dermatological health is further accelerating the market. Pet biotics are becoming strong contenders in various applications, including digestive health, skin and coat care, metabolic function, anxiety reduction, and senior pet wellness.

Owing to their strong global presence and expanding investments in microbiome technology, some major players in the pet biotics market include ADM (US), Alltech (US), Kerry Group plc (Ireland), International Flavors & Fragrances Inc. (US), dsm-firmenich (Netherlands), Cargill, Incorporated (US), Kemin Industries, Inc. (US), Probi (Sweden), BENEO GmbH (Germany), Ingredion (US), Novonesis Group (Denmark), Lallemand Inc. (Canada), Phileo by Lesaffre (France), Sacco System (Italy), and Sanzyme Biologics (India). Companies are adopting a mix of organic and inorganic growth strategies, including partnerships, acquisitions, product launches, strategic collaborations, and R&D expansion, to strengthen their position and meet the growing demand for functional pet nutrition from consumers.

Scientific research, clinical validation, and advanced strain stabilization and fermentation technologies are being increasingly employed by industry leaders to enhance product efficacy, shelf stability, and processing compatibility, especially for dry and extruded pet food formats. With e-commerce growth and a shift toward personalized and preventive pet care, major players are working to scale their pet biotics portfolios across pet food, treats, supplements, and veterinary prescription diets to establish a strong foothold in the global market.

Archer Daniels Midland Company, also known as ADM, produces and distributes food ingredients, animal feed & feed ingredients, biofuels, and naturally derived alternatives to industrial chemicals. ADM is one of the key players in the trading of commodities and processing of agricultural products. With more than a century of experience, ADM maintains a diverse portfolio of businesses that cover the entire value chain of agriculture. They efficiently connect farmers and producers with customers worldwide through their extensive network of origination facilities, processing plants, and logistics capabilities. ADM has a global presence across North America, South America, Europe, Asia Pacific, and Africa. It commands a robust global supply chain network that ensures consistency in quality, supported by 450 crop procurement locations, more than 330 food and feed ingredient manufacturing facilities, 62 innovation centers, and a supreme crop transportation network. The company faces stiff competition from key players, such as Cargill (US) and Kerry Group PLC (Ireland).

The company operates through four major segments: Ag Services and Oilseeds, Carbohydrate Solutions, Nutrition, and Other Business. ADM is a global leader in the nutrition segment. Within its Nutrition segment, ADM develops, manufactures, and distributes a wide range of specialty ingredients—such as postbiotics, probiotics, enzymes, and botanical extracts—serving diverse end markets including food, beverages, nutritional supplements, livestock feed, aquaculture, and pet nutrition. In June 2025, ADM opened a 1,600 m², state-of-the-art R&D center at Lausanne’s biopôle campus in Switzerland to conduct pre-clinical microbiome research for pets, livestock, and aquaculture—leveraging biotics and fermentation-derived ingredients to improve gut health, immunity, digestion, and longevity. This launch reflects the booming $5.2 billion global animal feed biotics market (as of 2024) and growing consumer and producer demand for science-backed nutritional solutions.

Alltech is a global leader in animal nutrition and biotechnology, dedicated to enhancing the health and performance of people, animals, and plants through advanced nutritional science and innovation. Guided by its core ACE principle—a commitment to positively impact the Animal, the Consumer, and the Environment—the company focuses on sustainable and research-driven solutions designed to enhance well-being across all stages of life. With a strong international footprint across Africa & the Middle East, Asia-Pacific, Europe, Latin America, and North America, Alltech delivers high-quality ingredients and technologies that support gut health, immunity, and metabolic balance in animals. In the pet nutrition segment, Alltech offers specialized feed ingredients designed to optimize the microbiome, promoting improved skin and coat condition, enhanced digestive function, increased mobility, and overall vitality in puppies, kittens, adult pets, and senior companion animals.

 In September 2023, Alltech introduced Microbuild, a new prebiotic fiber designed to support gut health in pets by promoting beneficial microbiota and improving digestive function. This innovation reflects the growing consumer demand for functional pet nutrition, positioning Alltech to strengthen its presence in the companion animal health market with scientifically backed solutions.

DSM-Firmenich is one of the leading companies in science-based solutions for health and nutrition. With a focus on innovation and sustainability, DSM provides a diverse range of products across multiple industries, including food, pharmaceuticals, animal nutrition, and personal care. In May 2023, DSM (Netherlands) and Switzerland-based Firmenich International SA merged to establish DSM-Firmenich (Switzerland). The merger between DSM and Firmenich International SA aimed to establish DSM-Firmenich as the foremost partner for creation and innovation in nutrition, beauty, and well-being. With a combined revenue of approximately USD 13.17 billion, the new entity now operates across five segments: Taste, Texture & Health, Health, Nutrition & Care, Animal Nutrition & Health, and Corporate Activities. DSM’s Taste, Texture & Health (TTH) segment consists of Taste, which includes the segments flavors, natural extracts, sugar reduction solutions, and Ingredients Solutions, which includes food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The four growth platforms – plant-based, sugar reduction, pet food, and health benefits solutions – deploy portfolios and capabilities across these two divisions. Pet biotics are offered under the Petfood platform within the TTH segment, supporting advanced nutrition and health solutions for companion animals.

Kerry Group plc is an Irish-headquartered global leader in taste and nutrition, providing innovative ingredient solutions for food, beverage, and pharmaceutical applications, all with an eye toward enhancing health and wellness through science-based, clean-label ingredients. Kerry has a geographical presence in over 140 countries across North America, Europe, South America, Asia Pacific, the Middle East, and Africa. It operates over 147 manufacturing sites in 32 countries across all six continents. Some of its major subsidiaries include Oakhouse Foods (UK), Island Oasis Inc. (US), Sucrest GmbH (Germany), Ganeden (US), Big Train Inc. (US), Oregon Chai (US), and Pevesa Biotech SA (Spain).

The company’s probiotics & postbiotic offerings are a part of its Taste & Nutrition business segment. Under Kerry Group’s Taste & Nutrition segment, the company offers a range of supplements focused on digestive health, including innovative postbiotic solutions. These science-backed products are designed to support digestive regulation and promote a healthy microbial balance, addressing the growing demand for personalized gut health benefits. Kerry’s commitment to advancing microbiome-based solutions positions it at the forefront of next-generation digestive health offerings within the nutrition market.

In August 2024, Kerry announced a two-year strategic partnership with APC Microbiome Ireland at University College Cork to collaboratively research and develop novel biotic and postbiotic ingredients targeting the gut–brain axis, with the aim of improving cognitive health and mood, and a rapid market rollout following project completion.

Market Ranking

The pet biotics market is driven by increasing consumer demand for scientifically backed, clinically supported, and shelf-stable solutions that improve pet gut health, immunity, and overall wellness. As pet owners increasingly prioritize preventive healthcare and natural nutrition for their companion animals, the pet biotics market continues to evolve to maintain competitiveness. Continuous product innovation, veterinary research, and aggressive expansion strategies enable major players to strengthen their market position. Key companies leading the global pet biotics landscape include ADM (US), Alltech (US), Kerry Group plc (Ireland), International Flavors & Fragrances Inc. (US), dsm-firmenich (Netherlands), Cargill, Incorporated (US), Probi (Sweden), Kemin Industries, Inc. (US), BENEO GmbH (Germany), Ingredion (US), and Lallemand Inc. (Canada). These top-tier companies rely on advanced fermentation technologies, microbiome science, and strong supply chain networks within the global pet nutrition ecosystem. Their capability to cater to a diverse range of end-use applications, including pet food, dietary supplements, functional treats, veterinary therapeutic formulations, and animal health solutions, provides a substantial competitive advantage. Partnerships with veterinarians, microbiologists, ingredient manufacturers, and academic research institutes further enhance their credibility and broaden their consumer base across premium and performance nutrition categories.

Meanwhile, emerging companies and startups are reshaping the competitive landscape by introducing targeted species-specific formulations, new microbial strains, precision microbiome diagnostics, and innovative delivery systems such as soft chews, probiotic powders, oral gels, and postbiotic-infused functional treats. With a smaller market share but strong R&D agility, these players contribute significantly to market dynamism. Their growth is expected to accelerate with increased investment, clinical validation, and strategic marketing focused on global expansion and veterinary endorsements.

Related Reports:

Pet Biotics Market By Type (Probiotics, Prebiotics, and Postbiotics), Application (Dry, Wet, Supplements, and Snacks & Treats), Pet (Dogs, Cats, and Other Pets), Form, Function, Manufacturing Technology, and Region – Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com